NASDAQ: ELTXElicio Therapeutics Inc Stock Ownership - Who owns Elicio Therapeutics?
Insider buying vs selling
Have Elicio Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Yekaterina Chudnovsky | Director | 2025-03-05 | 3,500,573 | $5.81 | $20.34MBuy |
| Peter Demuth | Chief Scientific Officer | 2024-12-16 | 381 | $4.41 | $1.68kBuy |
| Jay Venkatesan | Director | 2024-11-26 | 50,000 | $0.01 | $500.00Buy |
ELTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ELTX insiders and whales buy or sell their stock.
ELTX Shareholders
What type of owners hold Elicio Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Yekaterina Chudnovsky | 33.86% | 5,416,212 | $61.47M | Insider |
| Eisaabc LLC | 17.13% | 2,740,978 | $31.11M | Insider |
| Itzhak Goldberg | 10.55% | 1,687,986 | $19.16M | Insider |
| Victor F. Ganzi | 6.12% | 978,698 | $11.11M | Insider |
| Knoll Capital Management LLC | 3.94% | 630,915 | $7.16M | Institution |
| Vanguard Group Inc | 2.84% | 454,619 | $5.16M | Institution |
| Jay Venkatesan | 1.13% | 180,534 | $2.05M | Insider |
| Geode Capital Management LLC | 0.76% | 120,831 | $1.37M | Institution |
| Gilbert S. Omenn | 0.50% | 80,326 | $911.70k | Insider |
| Northern Trust Corp | 0.32% | 51,000 | $578.85k | Institution |
ELTX vs Biotech Stocks
Elicio Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.